全文获取类型
收费全文 | 5605篇 |
免费 | 189篇 |
国内免费 | 19篇 |
出版年
2023年 | 196篇 |
2022年 | 132篇 |
2021年 | 173篇 |
2020年 | 176篇 |
2019年 | 301篇 |
2018年 | 236篇 |
2017年 | 225篇 |
2016年 | 169篇 |
2015年 | 237篇 |
2014年 | 532篇 |
2013年 | 563篇 |
2012年 | 465篇 |
2011年 | 438篇 |
2010年 | 359篇 |
2009年 | 228篇 |
2008年 | 177篇 |
2007年 | 210篇 |
2006年 | 157篇 |
2005年 | 129篇 |
2004年 | 123篇 |
2003年 | 74篇 |
2002年 | 55篇 |
2001年 | 26篇 |
2000年 | 25篇 |
1999年 | 24篇 |
1998年 | 32篇 |
1997年 | 28篇 |
1996年 | 18篇 |
1995年 | 23篇 |
1994年 | 17篇 |
1993年 | 19篇 |
1992年 | 6篇 |
1991年 | 11篇 |
1990年 | 7篇 |
1989年 | 5篇 |
1988年 | 5篇 |
1987年 | 6篇 |
1986年 | 5篇 |
1985年 | 8篇 |
1984年 | 30篇 |
1983年 | 24篇 |
1982年 | 21篇 |
1981年 | 18篇 |
1980年 | 16篇 |
1979年 | 14篇 |
1978年 | 8篇 |
1977年 | 12篇 |
1976年 | 15篇 |
1975年 | 18篇 |
1973年 | 7篇 |
排序方式: 共有5813条查询结果,搜索用时 15 毫秒
991.
992.
Jia Liu Liang Han Bin Li Jie Yang Michael S. Y. Huen Xin Pan Sai Wah Tsao Annie L. M. Cheung 《The Journal of biological chemistry》2014,289(31):21508-21518
The p38 MAPK signal transduction pathway plays an important role in inflammatory and stress responses. MAPKK6 (MKK6), a dual specificity protein kinase, is a p38 activator. Activation of the MKK6-p38 pathway is kept in check by multiple layers of regulations, including autoinhibition, dimerization, scaffold proteins, and Lys-63-linked polyubiquitination. However, the mechanisms underlying deactivation of MKK6-p38, which is crucial for maintaining the magnitude and duration of signal transduction, are not well understood. Lys-48-linked ubiquitination, which marks substrates for proteasomal degradation, is an important negative posttranslational regulatory machinery for signal pathway transduction. Here we report that the accumulation of F-box only protein 31 (FBXO31), a component of Skp1·Cul1·F-box protein E3 ligase, negatively regulated p38 activation in cancer cells upon genotoxic stresses. Our results show that FBXO31 binds to MKK6 and mediates its Lys-48-linked polyubiquitination and degradation, thereby functioning as a negative regulator of MKK6-p38 signaling and protecting cells from stress-induced cell apoptosis. Taken together, our findings uncover a new mechanism of deactivation of MKK6-p38 and substantiate a novel regulatory role of FBXO31 in stress response. 相似文献
993.
Yongqiang Chen Huijun Wei Fei Liu Jun-Lin Guan 《The Journal of biological chemistry》2014,289(2):1164-1173
The mammalian target of rapamycin complex 1 (mTORC1) is a master regulator of cell growth and proliferation. Recent studies have suggested that constitutive activation of mTORC1 in normal cells could lead to malignant tumor development in several tissues. However, the mechanisms of mTORC1 hyperactivation to promote the growth and metastasis of breast or other cancers are still not well characterized. Here, using a new inducible deletion system, we show that deletion of Tsc1 in mouse primary mammary tumor cells, either before or after their transplantation, significantly increased their growth in vivo. The increase in tumor growth was completely rescued by rapamycin treatment, suggesting a major contribution from mTORC1 hyperactivation. Interestingly, glucose starvation-induced autophagy, but not amino acid starvation-induced autophagy, was increased significantly in Tsc1-null tumor cells. Further analysis of these cells also showed an increased Akt activation but no significant changes in Erk signaling. Together, these results provide insights into the mechanism by which hyperactivation of mTORC1 promotes breast cancer progression through increasing autophagy and Akt activation in vivo. 相似文献
994.
995.
996.
Mohd Askandar Iqbal Farid Ahmad Siddiqui Noor Chaman Vibhor Gupta Bhupender Kumar Prakasam Gopinath Rameshwar N. K. Bamezai 《The Journal of biological chemistry》2014,289(12):8098-8105
The present study was designed to examine the functional relevance of two heterozygous mutations (H391Y and K422R), observed earlier by us in the Bloom syndrome condition. Cells stably expressing exogenous wild-type or mutant PKM2 (K422R or H391Y) or co-expressing both wild type and mutant (PKM2-K422R or PKM2-H391Y) were assessed for cancer metabolism and tumorigenic potential. Interestingly, cells co-expressing PKM2 and mutant (K422R or H391Y) showed significantly aggressive cancer metabolism as compared with cells expressing either wild-type or mutant PKM2 independently. A similar trend was observed for oxidative endurance, tumorigenic potential, cellular proliferation, and tumor growth. These observations signify the dominant negative nature of mutations. Remarkably, PKM2-H391Y co-expressed cells showed a maximal effect on all the studied parameters. Such a dominant negative impaired function of PKM2 in tumor development is not known; this study demonstrates for the first time the possible predisposition of Bloom syndrome patients with impaired PKM2 activity to cancer and the importance of studying genetic variations in PKM2 in the future to understand their relevance in cancer in general. 相似文献
997.
998.
Courtney L. Jones Teena Bhatla Roy Blum Jinhua Wang Steven W. Paugh Xin Wen Wallace Bourgeois Danielle S. Bitterman Elizabeth A. Raetz Debra J. Morrison David T. Teachey William E. Evans Michael J. Garabedian William L. Carroll 《The Journal of biological chemistry》2014,289(30):20502-20515
Although great advances have been made in the treatment of pediatric acute lymphoblastic leukemia, up to one of five patients will relapse, and their prognosis thereafter is dismal. We have previously identified recurrent deletions in TBL1XR1, which encodes for an F-box like protein responsible for regulating the nuclear hormone repressor complex stability. Here we model TBL1XR1 deletions in B-precursor ALL cell lines and show that TBL1XR1 knockdown results in reduced glucocorticoid receptor recruitment to glucocorticoid responsive genes and ultimately decreased glucocorticoid signaling caused by increased levels of nuclear hormone repressor 1 and HDAC3. Reduction in glucocorticoid signaling in TBL1XR1-depleted lines resulted in resistance to glucocorticoid agonists, but not to other chemotherapeutic agents. Importantly, we show that treatment with the HDAC inhibitor SAHA restores sensitivity to prednisolone in TBL1XR1-depleted cells. Altogether, our data indicate that loss of TBL1XR1 is a novel driver of glucocorticoid resistance in ALL and that epigenetic therapy may have future application in restoring drug sensitivity at relapse. 相似文献
999.
Dong-Joo You Cho Rong Park Hyun Bok Lee Mi Jin Moon Ju-Hee Kang Cheolju Lee Seong-Hyun Oh Curie Ahn Jae Young Seong Jong-Ik Hwang 《The Journal of biological chemistry》2014,289(25):17709-17720
IKKβ functions as a principal upstream activator of the canonical NF-κB pathway by phosphorylating IκB, leading to its proteasomal degradation. Because IKKβ is considered a therapeutic target, understanding its regulation may facilitate the design of efficient regulators of this molecule. Here, we report a novel IKKβ-interacting molecule, NME1L, a splicing variant of the NME1 protein. NME1 has attracted attention in cancer research because of its antimetastatic activity and reduced expression in multiple aggressive types of cancer. However, the effect was just moderate but not dramatic in anti-cancer activities. We found that only NME1L interacts with IKKβ. Exogenous expression of NME1L resulted in a potent decrease in TNFα-stimulated NF-κB activation, whereas knockdown of NME1/NME1L with shRNA enhanced activity of NF-κB. NME1L down-regulates IKKβ signaling by blocking IKKβ-mediated IκB degradation. When NME1L was introduced into highly metastatic HT1080 cells, the mobility was efficiently inhibited. Furthermore, in a metastasis assay, NME1L-expressing cells did not colonize the lung. Based on these results, NME1L is a potent antimetastatic protein and may be a useful weapon in the fight against cancers. 相似文献
1000.
Kazutaka Sumita Hirofumi Yoshino Mika Sasaki Nazanin Majd Emily Rose Kahoud Hidenori Takahashi Koh Takeuchi Taruho Kuroda Susan Lee Pascale G. Charest Kosuke Takeda John M. Asara Richard A. Firtel Dimitrios Anastasiou Atsuo T. Sasaki 《The Journal of biological chemistry》2014,289(7):3950-3959
Mammalian cells encode three closely related Ras proteins, H-Ras, N-Ras, and K-Ras. Oncogenic K-Ras mutations frequently occur in human cancers, which lead to dysregulated cell proliferation and genomic instability. However, mechanistic role of the Ras isoform regulation have remained largely unknown. Furthermore, the dynamics and function of negative regulation of GTP-loaded K-Ras have not been fully investigated. Here, we demonstrate RasG, the Dictyostelium orthologue of K-Ras, is targeted for degradation by polyubiquitination. Both ubiquitination and degradation of RasG were strictly associated with RasG activity. High resolution tandem mass spectrometry (LC-MS/MS) analysis indicated that RasG ubiquitination occurs at C-terminal lysines equivalent to lysines found in human K-Ras but not in H-Ras and N-Ras homologues. Substitution of these lysine residues with arginines (4KR-RasG) diminished RasG ubiquitination and increased RasG protein stability. Cells expressing 4KR-RasG failed to undergo proper cytokinesis and resulted in multinucleated cells. Ectopically expressed human K-Ras undergoes polyubiquitin-mediated degradation in Dictyostelium, whereas human H-Ras and a Dictyostelium H-Ras homologue (RasC) are refractory to ubiquitination. Our results indicate the existence of GTP-loaded K-Ras orthologue-specific degradation system in Dictyostelium, and further identification of the responsible E3-ligase may provide a novel therapeutic approach against K-Ras-mutated cancers. 相似文献